posted
Related Quotes Sym. Price Chg. MGEN Trade News 0.0012 0.0001 Med Gen Announces New Marketing Programs
Aug 6, 2007 11:52:06 (ET)
BOCA RATON, Fla., Aug 06, 2007 (BUSINESS WIRE) -- Med Gen Inc. (MGEN, Trade ) ("MGEN"), manufacturers of nationally branded OTC healthier life products, reports a major marketing effort for, Therapedic C.I.(TM) Innersoles, Snorenz(R) and Painenz(R) during the months of August, September and October.
The marketing for Snorenz(R) and Painenz(R) is in the form of a full Color Mailer that will be sent to 1.4 million homes. Purchasers can either use the Med Gen "Call Room" or be directed to a new Internet site designed specifically for this promotion at www.medgencorp.com . The promotion will feature a mix & match 2 bottle price at $19.95 Freight Free. Therapedic C.I.(TM) Comfort Innersoles (formerly Footfridge(R)) will be featured in TV commercials which will start airing in 2-3 weeks.
"This promotion will signal an aggressive new marketing approach by the company that will continue thru 2008. The company has budgeted $1 million to cover the promotion costs. The promotions will run the gamut of Radio, TV, Print and Mailers. We have hired professionals in all fields of marketing and sales during the past months to make sure we get off to a good start," said Paul Mitchell, President.
About Med Gen Inc.
Med Gen Inc., in business since 1996, manufactures and markets specialty products using its proprietary delivery system Spray's the Way ("STW"). It is best known for producing the world's first patented liquid spray snoring relief formula, Snorenz(R). Since its existence, Med Gen has continued to develop its STW technology, introducing Good Nights Sleep(R) and the UnDiet(R) system into its family of brands. While STW technology is mainly used, the company also produces other products that deal with common health issues using other delivery systems. One such product is Painenz(R). Recently, the company formed a joint venture to market Therapedic C.I.(TM) an innovative and patented innersole, that amongst other attributes, cools and comforts the feet. The company markets its products to distributors, major chain and drug stores, direct sales via the company web site and direct to consumer television, radio and print advertising. The company also distributes its brands internationally under various private labels or existing names. The Company also offers specialty services to small emerging public companies in similar fields as a way of adding assets to its base business.
Med Gen Inc. is a fully reporting company whose stock trades on the OTCBB under the symbol "MGEN". For information contact Investor Relations 561-750-1100 or www.medgen.com .
This Press Release contains or incorporates by reference "forward looking statements including certain information with respect to plans and strategies of Med Gen Inc. For this purpose, any statements contained herein or incorporated herein by references that are not statements of historical fact may be deemed forward looking statements. Without limiting the foregoing, the words "believes", "suggests", "anticipates", "plans", "expects", and similar expressions are intended to identify forward looking statements. There are a number of events or actual results of Med Gen operations that could differ materially from those indicated by such forward looking statements.
SOURCE: Med Gen Inc.
Med Gen Inc., Boca Raton Paul Kravitz, 561-750-1100
BOCA RATON, Fla., Aug 09, 2007 (BUSINESS WIRE) -- Med Gen Inc. (MGEN, Trade ), manufacturers of nationally branded OTC healthier life products and specialty financial services, reports on its third quarterly results.
The quarterly results indicate an expanding diversified enterprise with sales increasing over 2,000% to $739,129 in this Quarter as compared to the like quarter of 2006. Much of the revenue for the quarter was generated by the company's financial services division, which has been expected and necessary to support the company's effort to redesign commercials and packaging for its product and marketing launches that are expected to take place in the fall. Nine month comparisons show similar increases with sales of $1,416,899, a 692% increase.
While the financials show a working capital deficit caused by a non-cash accounting of a "Registration Penalty" embodied in loan documents from its lenders, the company actually is in an extremely good cash position with better than $1,400,000 in current assets of which $1,387,000 is in cash. The company reported a gross profit for the June quarter of $625,691 and for the nine months $1,138,488. Net losses for the quarter and the nine months were reported as $2,987,229 and $5,667,016 respectively. Substantially all the losses were attributable to Derivative (non-cash) Instruments.
For further information, the complete financials are on file at www.edgar.gov .
About Med Gen Inc.
Med Gen Inc., in business since 1996, manufactures and markets specialty products using its proprietary delivery system Spray's the Way ("STW"). It is best known for producing the world's first patented liquid spray snoring relief formula, Snorenz(R). Since its existence, Med Gen has continued to develop its STW technology, introducing Good Nights Sleep(R) and the UnDiet(R) system into its family of brands. While STW technology is mainly used, the company also produces other products that deal with common health issues using other delivery systems. Recently, the company formed a joint venture to market Therapedic C.I.(R), an innovative and patented innersole, that amongst other attributes, cools and comforts the feet. The company markets its products to distributors, major chain and drug stores, direct sales via the company web site and direct to consumer television, radio and print advertising. The company also distributes its brands internationally under various private labels or existing names. The Company, through its Financial Services division, offers specialty services to small emerging public companies.
Med Gen Inc. is a fully reporting company whose stock trades on the OTCBB under the symbol "MGEN". For information contact Investor Relations 561-750-1100 or www.medgen.com
This Press Release contains or incorporates by reference "forward looking statements including certain information with respect to plans and strategies of Med Gen Inc. For this purpose, any statements contained herein or incorporated herein by references that are not statements of historical fact may be deemed forward looking statements. Without limiting the foregoing, the words "believes", "suggests", "anticipates", "plans", "expects", and similar expressions are intended to identify forward looking statements. There are a number of events or actual results of Med Gen operations that could differ materially from those indicated by such forward looking statements.
SOURCE: Med Gen Inc.
Med Gen Inc., Boca Raton Paul Kravitz, 561-750-1100
BOCA RATON, Fla., Aug 10, 2007 (BUSINESS WIRE) -- Med Gen Inc. (MGEN, Trade ) ("MGEN"), manufacturers of nationally branded OTC healthier life products and specialty financial services files Form 8K which indicates a pay down of 21% on its $6 million debt.
"The company intends to further reduce its debt with revenue from its new marketing promotions which are scheduled starting in mid August thru November," said Paul Kravitz, Med Gen Chairman/CEO. "Our Shareholders are asking for a boost in share price and, if possible, we intend to give it to them."
Med Gen Inc., in business since 1996, manufactures and markets specialty products using its proprietary delivery system Spray's the Way ("STW"). It is best known for producing the world's first patented liquid spray snoring relief formula, Snorenz(R). Since its existence, Med Gen has continued to develop its STW technology, introducing Good Nights Sleep(R) and the UnDiet(R) system into its family of brands. While STW technology is mainly used, the company also produces other products that deal with common health issues using other delivery systems. Recently, the company formed a joint venture to market FootFridge(R), an innovative and patented innersole, that amongst other attributes, cools and comforts the feet. The company markets its products to distributors, major chain and drug stores, direct sales via the company web site and direct to consumer television, radio and print advertising. The company also distributes its brands internationally under various private labels or existing names. The Company, through its Financial Services Division, offers specialty services to small emerging public companies.
Med Gen Inc. is a fully reporting company whose stock trades on the OTCBB under the symbol "MGEN". For information contact Investor Relations 561-750-1100 or www.medgen.com
This Press Release contains or incorporates by reference "forward looking statements" including certain information with respect to plans and strategies of Med Gen Inc. For this purpose, any statements contained herein or incorporated herein by references that are not statements of historical fact may be deemed forward looking statements. Without limiting the foregoing, the words "believes", "suggests", "anticipates", "plans", "expects", and similar expressions are intended to identify forward looking statements. There are a number of events or actual results of Med Gen operations that could differ materially from those indicated by such forward looking statements.
SOURCE: Med Gen Inc.
Med Gen Inc., Boca Raton Paul Kravitz, 561-750-1100
posted
In the whole picture, you have to love the fact that they have started reducing their debt. That's a strong quality in a company; it's definitely telling me that they're showing their responsibility and maturity. That and the fact that they're constantly increasing revenue are big pluses (especially among the penny stocks).
Finally, look at the last statement that the CEO made: "Our Shareholders are asking for a boost in share price and, if possible, we intend to give it to them." They're looking to improve their P/S, I'm betting this stock is going to start a big run any day now.
Posts: 196 | From: SoCal SD | Registered: Mar 2006
| IP: Logged |
posted
Hey IMAKE, do you own this stock at all? or were you just keeping an eye on it? The price just seems too good to pass right now. I wish my 0.0009 order fills
Posts: 196 | From: SoCal SD | Registered: Mar 2006
| IP: Logged |
posted
IN AT .0010- Med Gen Launches Fall Promotion Season
Aug 15, 2007 14:31:28 (ET)
BOCA RATON, Fla., Aug 15, 2007 (BUSINESS WIRE) -- Med Gen Inc. (MGEN, Trade ) ("MGEN"), manufacturers of nationally branded OTC healthier life products and specialty financial services announces the early start of its fall promotion schedule.
Just released, Painenz(R) and Snorenz(R) are featured products in a 500,000 piece mailer to readers of Gardening magazine. In a test program, Gardening ranked Painenz(R) at the top, with a better than 75% approval rating amongst its club members. The Painenz(R) mailer is joined with Snorenz(R), the company's flag ship snore relief product. A 2% return would generate $120,000 in revenue with carry forward business.
The release of TheraPedic CS(TM) (innersoles) TV shows is scheduled for end of August broadcasting. The renaming of FootFridge(R) to TheraPedic(TM) and a re-make of the commercial was the result of several test airings. "We believe in this patented product that is useful for diabetic sufferers, sportsmen and the general public. I have never walked with so much comfort before," said Paul Kravitz, company Chairman & CEO.
UnDiet(R) and Good Nights Sleep(R) commercials are also being readied for October-November. Lastly is the scheduling of FabuLust(R) female stimulant. "Our plate is full and we are expecting to generate significant revenue from these activities as the company moves into full swing for the coming retail season," said Kravitz.
All products can be viewed and purchased on www.medgen.com .
About Med Gen Inc.
Med Gen Inc., in business since 1996, manufactures and markets specialty products using its proprietary delivery system Spray's the Way ("STW"). It is best known for producing the world's first patented liquid spray snoring relief formula, Snorenz(R). Since its existence, Med Gen has continued to develop its STW technology, introducing Good Nights Sleep(R) and the UnDiet(R) system into its family of brands. While STW technology is mainly used, the company also produces other products that deal with common health issues using other delivery systems. Recently, the company formed a joint venture to market TheraPedic(R) an innovative and patented innersole, that amongst other attributes, cools and comforts the feet. The company markets its products to distributors, major chain and drug stores, direct sales via the company web site and direct to consumer television, radio and print advertising. The company also distributes its brands internationally under various private labels or existing names. The Company also offers specialty services to small emerging public companies in similar fields as a way of adding assets to its base business.
Med Gen Inc. is a fully reporting company whose stock trades on the OTCBB under the symbol "MGEN". For information contact Investor Relations 561-750-1100 or www.medgen.com .
This Press Release contains or incorporates by reference "forward looking statements including certain information with respect to plans and strategies of Med Gen Inc. For this purpose, any statements contained herein or incorporated herein by references that are not statements of historical fact may be deemed forward looking statements. Without limiting the foregoing, the words "believes", "suggests", "anticipates", "plans", "expects", and similar expressions are intended to identify forward looking statements. There are a number of events or actual results of Med Gen operations that could differ materially from those indicated by such forward looking statements.
SOURCE: Med Gen Inc.
Med Gen Inc., Boca Raton Paul Kravitz, 561-750-1100
posted
From the last two 10Qs, the O/S increased about 300 M shares in 3 months. The estimated o/s is about 900 M shares now, simililar to FMLY, which bottomed at 0.0004 and bounced back to 0.0009. The MMs have shorted many stocks over 500 M shares to 0.0004. This is the way they make money.
The MMs are shorting this one, too.
From ShortSqueeze report:
MGEN Shares Short 435,200 Shares Short - Prior 220,700 Short % Increase / Decrease 97.19 %
Posts: 3228 | From: Michigan | Registered: Aug 2005
| IP: Logged |
posted
I don’t understand, the company paid back a big portion of their debt. Meaning they're doing so great now that they can focus on paying their debt. THUS they have money to spare, because they're making lots of it. SO, what the hell? Why isn't the PS showing a positive swing? Can anyone answer this for me?
Posts: 196 | From: SoCal SD | Registered: Mar 2006
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Wink]](wink.gif)
Med Gen Launches Fall Promotion Season 
